Cheryl VerStrate, DNP, AGPCNP-BC, OCN, is a renowned expert in the field of cancer genetics, and she highlights the potential pitfalls of at-home genomic tests like 23andMe. As these direct-to-consumer genetic tests gain popularity, more patients with cancer may opt for them instead of seeking genetic counseling. However, according to VerStrate, oncology nurses must be prepared to discuss the limitations of these tests and advocate for genetic counseling whenever possible.

Nurses often play a crucial role in answering patients' questions and providing them with comprehensive and ethically sound education on genetic testing. VerStrate's research sheds light on the risks associated with direct-to-consumer testing and dispels common misconceptions. These tests may be perceived as cheaper and more convenient, but they lack adequate analysis and may lead to misinterpretation of results.

Additionally, the absence of pre- and post-test counseling raises concerns about informed consent and the potential psychological impact of unprepared results. Nurses should be aware of these ethical considerations and advocate for comprehensive genetic counseling for their patients